Core Laboratories (NYSE:CLB – Get Free Report) updated its fourth quarter earnings guidance on Wednesday. The company provided earnings per share guidance of $0.20-0.25 for the period, compared to the consensus earnings per share estimate of $0.24. The company issued revenue guidance of $128.5-135.5 million, compared to the consensus revenue estimate of $134.60 million. Core Laboratories also updated its Q4 2024 guidance to 0.200-0.250 EPS.
Analyst Upgrades and Downgrades
CLB has been the subject of several research analyst reports. Bank of America reduced their price objective on Core Laboratories from $16.00 to $15.00 and set an “underperform” rating for the company in a report on Monday, July 15th. StockNews.com downgraded Core Laboratories from a “hold” rating to a “sell” rating in a report on Tuesday, September 17th. Stifel Nicolaus lifted their price objective on Core Laboratories from $18.00 to $22.00 and gave the stock a “hold” rating in a report on Friday, July 26th. Finally, Piper Sandler reduced their price objective on Core Laboratories from $18.00 to $17.00 and set a “neutral” rating for the company in a report on Monday, July 15th. Two research analysts have rated the stock with a sell rating and two have given a hold rating to the stock. According to data from MarketBeat, Core Laboratories currently has an average rating of “Hold” and a consensus target price of $18.00.
Get Our Latest Report on Core Laboratories
Core Laboratories Stock Performance
Core Laboratories (NYSE:CLB – Get Free Report) last announced its earnings results on Wednesday, July 24th. The oil and gas company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.01. The business had revenue of $130.58 million for the quarter, compared to analysts’ expectations of $132.85 million. Core Laboratories had a return on equity of 15.20% and a net margin of 5.44%. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period last year, the firm posted $0.23 earnings per share. As a group, research analysts predict that Core Laboratories will post 0.8 earnings per share for the current year.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
See Also
- Five stocks we like better than Core Laboratories
- How Technical Indicators Can Help You Find Oversold Stocks
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What Does a Stock Split Mean?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Are Penny Stocks a Good Fit for Your Portfolio?
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.